Create Medicines is pioneering in vivo immune cell programming with RNA powered, LNP delivered CAR therapies – unlocking scalable, off-the-shelf treatments for cancer, autoimmunity, and fibrosis
Location: United States
Investors 1
| Date | Name | Website |
| 07.11.2025 | Newpath Ma... | newpath.pa... |
Mentions in press and media 1
| Date | Title | Description |
| 14.05.2026 | Create Medicines Raises $122M in Series B Funding | Create Medicines, Inc., a Cambridge, Massachusetts-based developer of in vivo immune programming and mRNA-LNP cell therapies, raised $122m in Series B funding. The round was co-led by existing investors Newpath Partners, ARCH Venture Partne... |